AwesomeCapital
Search This Blog
Friday, December 27, 2019
Castle Biosciences target upped to $35 from $34 by Canaccord
Maintains Buy.
https://www.benzinga.com/stock/CSTL/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.